V will Establish Company’s 3rd International Center SAN FRANCISCO, CA, April 29, 2022 (GLOBE NEWSWIRE) -- }via NewMediaWire ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has signed a joint… Read More..

Company expects to launch pivotal Phase 3 ASCEND clinical trial to evaluate TMB-001 within the next 60 days BASKING RIDGE, NJ - April 28, 2022 - Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare… Read More..

- Top line Data from the FORTRESS Study Expected in September 2022 - ATLANTA--Virios Therapeutics, Inc.(Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including announced today that it has completed enrollment in its Phase 2b FORTRESS (Fibromyalgia Outcome Research Trial… Read More..